Cincinnati Univ Of
UEI DZ4YCZ3QSPR5 · OH · SAM.gov record ↗
$3.0M
FY2025 obligations
25
Contract awards
Jul 16, 2013
First action
Sep 30, 2025
Latest action
Obligations by agency
- Department Of Health And Human Services$2.5M
- Department Of Defense$366K
- Department Of Veterans Affairs$133K
- Environmental Protection Agency$-2K
Obligations by NAICS
Monthly obligations
Oct 24
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Sep 25
Contracts ending within 18 months (recompete watch)
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75N94020F00001 ↗ | AWARD TASK ORDER 1 TO PROVIDE ASSISTANCE IN PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVITIES ASSOCIATED WITH PAST, PRESENT AND FUTURE CCTN ACTIVITIES. | National Institutes Of Health | 541714 | $3K | Aug 1, 2020 | Jul 31, 2026 |
| W81XWH21C0075 ↗ | IMPROVING NEUROTRAUMA BY DEPOLARIZATION INHIBITION WITH COMBINATION THERAPY | Department Of The Army | 541715 | $0 | Sep 21, 2021 | Sep 20, 2026 |
| 75A50123C00052 ↗ | THE SCOPE OF WORK FOR THIS CONTRACT INCLUDES THE DEVELOPMENT AND VALIDATION OF BIOTIN AS AN IN VIVO LABELLING AGENT FOR RED BLOOD CELLS TO REPLACE CHROMIUM 51 AS THE STANDARD FDA-APPROVED TECHNOLOGY FOR ASSESSING THE LIFESPAN OF RBCS IN CIRCULATION. | Office Of Assistant Secretary For Preparedness And Response | 611310 | $2.6M | Sep 21, 2023 | Sep 30, 2026 |
Largest awards
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75A50123C00052 ↗ | THE SCOPE OF WORK FOR THIS CONTRACT INCLUDES THE DEVELOPMENT AND VALIDATION OF BIOTIN AS AN IN VIVO LABELLING AGENT FOR RED BLOOD CELLS TO REPLACE CHROMIUM 51 AS THE STANDARD FDA-APPROVED TECHNOLOGY FOR ASSESSING THE LIFESPAN OF RBCS IN CIRCULATION. | Office Of Assistant Secretary For Preparedness And Response | 611310 | $2.6M | Sep 21, 2023 | Sep 30, 2026 |
| N0001425C1509 ↗ | THIS EFFORT IS EVALUATING THE PROSPECTIVE BENEFITS OF APPLYING THE ROTATING DETONATION MODE OF COMBUSTION IN A GAS TURBINE AUGMENTOR SETTING. FOR EACH TASK, THE CONTRACTOR WILL CONDUCT DIAGNOSTICS FOR DESCRIBING PERFORMANCE AND OPERABILITY METRICS. | Department Of The Navy | 541715 | $307K | Aug 21, 2025 | Aug 21, 2028 |
| 36C25025C0078 ↗ | BLOOD AND BLOOD PRODUCTS | Department Of Veterans Affairs | 621991 | $300K | Mar 1, 2025 | Feb 28, 2026 |
| 75D30124P19936 ↗ | PARTNERSHIP FOR RESEARCH OF SENSING TECHNOLOGIES | Centers For Disease Control And Prevention | 541715 | $21K | Aug 30, 2024 | Dec 31, 2025 |
| N0622A25FA506 ↗ | TUITION AND FEES OH, UNIVERSITY OF CINCINNATI FALL 1301284172 | Department Of The Navy | 611310 | $18K | Aug 28, 2025 | Dec 31, 2025 |
| N0622A25FA017 ↗ | TUITION AND FEES FOR SPRING TERM | Department Of The Navy | 611310 | $18K | Jan 29, 2025 | Apr 30, 2025 |
| FA239625PB087 ↗ | USAFSAM/ET - FY25 CSTARS CINCINNATI CADAVER LAB SERVICES AT UNIVERSITY OF CINCINNATI | Department Of The Air Force | 611710 | $13K | Jul 7, 2025 | Sep 30, 2025 |
| N0622A25FA197 ↗ | OH, UNIVERSITY OF CINCINNATI TUITION AND FEES FOR SUMMER TERM MAY - AUG 2025 | Department Of The Navy | 611310 | $10K | Apr 3, 2025 | Aug 29, 2025 |
| 36C25025P1761 ↗ | BIOSKILLS LAB AND CADEVERIC LIMBS FOR EDUCATIONAL AND TRAINING VIDEO FOR REMOTE PATIENT PEDAL MONITORING. | Department Of Veterans Affairs | 611430 | $5K | Sep 30, 2025 | Sep 30, 2025 |
| 75N94020F00001 ↗ | AWARD TASK ORDER 1 TO PROVIDE ASSISTANCE IN PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVITIES ASSOCIATED WITH PAST, PRESENT AND FUTURE CCTN ACTIVITIES. | National Institutes Of Health | 541714 | $3K | Aug 1, 2020 | Jul 31, 2026 |
| 36C25024P0051 ↗ | RESEARCH FOR THE CINCINNATI VAMC | Department Of Veterans Affairs | 541715 | $263 | Dec 18, 2023 | Sep 30, 2025 |
| 75D30124P19472 ↗ | UNIVERSITY OF CINCINNATI SILVER BI-ANALYTICS MEMBERSHIP | Centers For Disease Control And Prevention | 611310 | $0 | Aug 1, 2024 | Jul 31, 2025 |
| 75N94023F00001 ↗ | PROTOCOL FINALIZATION, REGULATORY APPROVAL, START-UP, AND COMMENCEMENT OF RECRUITMENT, SCREENING, AND ENROLLMENT FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL | National Institutes Of Health | 541714 | $0 | Sep 28, 2023 | Dec 31, 2025 |
| 75N94020D00011 ↗ | IPP - TO CONDUCT PHASE I, II, III OR IV CONTRACEPTIVE TRIALS IN WOMEN, TREATMENT TRIALS OF GYNECOLOGIC CONDITIONS SUCH AS ENDOMETRIOSIS OR LEIOMYOMATA, AND DEVELOPMENT OF RESEARCH PROTOCOLS ON A TASK ORDER BASIS UNDER A SEVEN (7) YEAR IDIQ | National Institutes Of Health | 541714 | $0 | Aug 1, 2020 | — |
| 75D30122P14113 ↗ | EOI::IMPLEMENTING THE PRESIDENT'S DOGE COST EFFICIENCY INITIATIVE::EOI NOTICE OF TERMINATION FOR CONVENIENCE | Centers For Disease Control And Prevention | 541690 | $0 | Jun 1, 2022 | Apr 22, 2025 |
| W81XWH21C0075 ↗ | IMPROVING NEUROTRAUMA BY DEPOLARIZATION INHIBITION WITH COMBINATION THERAPY | Department Of The Army | 541715 | $0 | Sep 21, 2021 | Sep 20, 2026 |
| W81XWH16C0161 ↗ | RESEARCH AND DEVELOPMENT AWARD HYPOTHERMIA FOR PATIENTS REQUIRING EVACUATION OF SUBDURAL HEMATOMA: EFFECT ON SPREADING DEPLOARIZATIONS | Department Of The Army | 541712 | $-21 | Sep 30, 2016 | Jul 31, 2021 |
| HHSN27500002 ↗ | A MULTI-CENTER, RANDOMIZED STUDY TO EVALUATE THE PHARMACOKINETIC AND PHARMACODYNAMIC PROFILE, CONTRACEPTIVE EFFICACY AND SAFETY OF DAILY ORAL LOW DOSE ULIPRISTAL ACETATE | National Institutes Of Health | 541712 | $-28 | Jul 16, 2013 | Mar 31, 2022 |
| 68HE0B20P0415 ↗ | DEOBLIGATE EXCESS FUNDS - LEASE BIOSAFETY LEVEL-3 (BSL-3) LEVEL RATED FACILITY AT UNIVERSITY OF CINCINNATI | Environmental Protection Agency | 561210 | $-2K | Aug 19, 2020 | Apr 1, 2024 |
| 75D30118C00391 ↗ | BIOMARKER DETECTION DEVICES (LAB-ON-A-CHIP DEVICES AND PORTABLE ANALYZER) FOR PERFORMING IMMUNOASSAY | Centers For Disease Control And Prevention | 541990 | $-10K | Apr 26, 2018 | Apr 25, 2022 |
| HHSN27500004 ↗ | NICHD: R&D: CLINICAL EVALUATION OF LONG-ACTING REVERSIBLE CONTRACEPTIVES (LARC): NON-SEVERABLE | National Institutes Of Health | 541712 | $-22K | Sep 18, 2015 | Sep 30, 2022 |
| 75D30120P09344 ↗ | EOI::GSA DEFEND THE SPEND::EOI NOTICE OF TERMINATION FOR CONVENIENCE | Centers For Disease Control And Prevention | 541690 | $-27K | Sep 1, 2020 | Feb 12, 2025 |
| 75D30123P18096 ↗ | EOI::GSA DEFEND THE SPEND::EOI NOTICE OF TERMINATION FOR CONVENIENCE | Centers For Disease Control And Prevention | 541690 | $-68K | Sep 26, 2023 | Feb 12, 2025 |
| 36C25024C0070 ↗ | BLOOD AND BLOOD PRODUCTS | Department Of Veterans Affairs | 621991 | $-84K | Mar 1, 2024 | Feb 28, 2025 |
| 36C25023C0077 ↗ | BLOOD AND BLOOD PRODUCTS | Department Of Veterans Affairs | 621991 | $-88K | Mar 1, 2023 | Jan 31, 2024 |